EIDPARRY:NSE
E I D-Parry (India) Ltd
₹701.00
arrow_upward
+0.26%(+1.80) 1D
Oct 7, 3:30:02 PM GMT+5:30 · INR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EIDPARRY...
Open
₹698.00
High
₹701.75
Low
₹691.00
Mkt. cap
120.32B
Avg. vol.
572.34K
Volume
336.02K
P/E ratio
26.92
52-wk high
₹1,118.00
52-wk low
₹672.30
EPS
₹26.04
Shares outstanding
176.99M
No. of employees
2K
Open
₹698.00
High
₹701.75
Low
₹691.00
Mkt. cap
120.32B
Avg. vol.
572.34K
Volume
336.02K
P/E ratio
26.92
52-wk high
₹1,118.00
52-wk low
₹672.30
EPS
₹26.04
Shares outstanding
176.99M
No. of employees
2K
News stories
From web sources and news partners
ChartMill
·
35 minutes ago
Which dow jones stocks are moving on Wednesday?
The Motley Fool
·
39 minutes ago
The Stock Market Is Flashing a Warning Sign We Haven't Seen Since 2000. History Says Investors Should Do This Now.
TradingView
·
1 hour ago
S&P 500, Nasdaq retreat from record highs as yields and oil climb
Profile
EID Parry Limited is an Indian public company engaged in the manufacture and marketing of sugar and bio-products, headquartered in Chennai. EID Parry has been in business since 1788, making it the oldest surviving mercantile name in Chennai. It has many firsts to its credit, including the manufacturing of fertilizers for the first time in the Indian subcontinent. Wikipedia
About E I D-Parry (India) Ltd
Last report
Aug 13, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
90.18B / 7.78B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in INR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 116.24B | 103.16B | 78.70B | 90.18B |
Cost of goods sold | 90.62B | 80.19B | 61.07B | 68.78B |
Cost of revenue | 90.62B | 80.19B | 61.07B | 68.78B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 3.29B | 3.50B | 3.96B | 3.75B |
Operating expense | 15.23B | 16.65B | 13.77B | 16.32B |
Total operating expenses | 105.85B | 96.84B | 74.85B | 85.10B |
Operating income | 10.40B | 6.32B | 3.86B | 5.08B |
Other non operating income | 1.51B | 595.30M | -2.90B | 299.30M |
EBT including unusual items | 10.62B | 5.88B | -1.62B | 4.23B |
EBT excluding unusual items | 10.62B | 5.88B | 1.04B | 4.23B |
Income tax expense | 2.96B | 1.51B | 1.25B | 1.11B |
Effective tax rate | 27.88% | 25.67% | -76.89% | 26.33% |
Other operating expenses | 10.35B | 11.11B | 7.56B | 10.14B |
Net income | 4.24B | 2.32B | -3.33B | 1.42B |
Net profit margin | 3.65% | 2.25% | -4.23% | 1.57% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | 2.32B | - |
Interest expense | -1.29B | -1.03B | -752.50M | -1.15B |
Net interest expenses | -1.29B | -1.03B | 1.57B | -1.15B |
Depreciation and amortization charges | 1.58B | 2.04B | 2.26B | 2.43B |
EBITDA | 12.07B | 7.46B | 5.60B | 6.82B |
Gain or loss from assets sale | - | - | - | - |